Joshua J Field1, Janet Stocks2, Fenella J Kirkham3, Carol L Rosen4, Dennis J Dietzen5, Trisha Semon5, Jane Kirkby2, Pamela Bates5, Sinziana Seicean6, Michael R DeBaun7, Susan Redline4, Robert C Strunk8. 1. Department of Medicine, Washington University School of Medicine, St. Louis, MO. 2. Portex Respiratory Unit, University College London, Institute of Child Health, London, England. 3. Neurosciences Unit, University College London, Institute of Child Health, London, England. 4. Department of Pediatrics, Case School of Medicine, Cleveland, OH. 5. Department of Pediatrics, Washington University School of Medicine, St. Louis, MO. 6. Department of Epidemiology and Biostatistics, Case School of Medicine, Cleveland, OH. 7. Departments of Pediatrics, Neurology and Biostatistics, Washington University School of Medicine, St. Louis, MO. 8. Division of Allergy, Immunology, and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO. Electronic address: strunk@kids.wustl.edu.
Abstract
BACKGROUND: The high prevalence of airway hyperresponsiveness (AHR) among children with sickle cell anemia (SCA) remains unexplained. METHODS: To determine the relationship between AHR, features of asthma, and clinical characteristics of SCA, we conducted a multicenter, prospective cohort study of children with SCA. Dose response slope (DRS) was calculated to describe methacholine responsiveness, because 30% of participants did not achieve a 20% decrease in FEV1 after inhalation of the highest methacholine concentration, 25 mg/mL. Multiple linear regression analysis was done to identify independent predictors of DRS. RESULTS: Methacholine challenge was performed in 99 children with SCA aged 5.6 to 19.9 years (median, 12.8 years). Fifty-four (55%) children had a provocative concentration of methacholine producing a 20% decrease in FEV1<4 mg/mL. In a multivariate analysis, independent associations were found between increased methacholine responsiveness and age (P<.001), IgE (P=.009), and lactate dehydrogenase (LDH) levels (P=.005). There was no association between methacholine responsiveness and a parent report of a doctor diagnosis of asthma (P=.986). Other characteristics of asthma were not associated with methacholine responsiveness, including positive skin tests to aeroallergens, exhaled nitric oxide, peripheral blood eosinophil count, and pulmonary function measures indicating airflow obstruction. CONCLUSIONS: In children with SCA, AHR to methacholine is prevalent. Younger age, serum IgE concentration, and LDH level, a marker of hemolysis, are associated with AHR. With the exception of serum IgE, no signs or symptoms of an allergic diathesis are associated with AHR. Although the relationship between methacholine responsiveness and LDH suggests that factors related to SCA may contribute to AHR, these results will need to be validated in future studies.
BACKGROUND: The high prevalence of airway hyperresponsiveness (AHR) among children with sickle cell anemia (SCA) remains unexplained. METHODS: To determine the relationship between AHR, features of asthma, and clinical characteristics of SCA, we conducted a multicenter, prospective cohort study of children with SCA. Dose response slope (DRS) was calculated to describe methacholine responsiveness, because 30% of participants did not achieve a 20% decrease in FEV1 after inhalation of the highest methacholine concentration, 25 mg/mL. Multiple linear regression analysis was done to identify independent predictors of DRS. RESULTS:Methacholine challenge was performed in 99 children with SCA aged 5.6 to 19.9 years (median, 12.8 years). Fifty-four (55%) children had a provocative concentration of methacholine producing a 20% decrease in FEV1<4 mg/mL. In a multivariate analysis, independent associations were found between increased methacholine responsiveness and age (P<.001), IgE (P=.009), and lactate dehydrogenase (LDH) levels (P=.005). There was no association between methacholine responsiveness and a parent report of a doctor diagnosis of asthma (P=.986). Other characteristics of asthma were not associated with methacholine responsiveness, including positive skin tests to aeroallergens, exhaled nitric oxide, peripheral blood eosinophil count, and pulmonary function measures indicating airflow obstruction. CONCLUSIONS: In children with SCA, AHR to methacholine is prevalent. Younger age, serum IgE concentration, and LDH level, a marker of hemolysis, are associated with AHR. With the exception of serum IgE, no signs or symptoms of an allergic diathesis are associated with AHR. Although the relationship between methacholine responsiveness and LDH suggests that factors related to SCA may contribute to AHR, these results will need to be validated in future studies.
Authors: Nives Zimmermann; Nina E King; Johanne Laporte; Ming Yang; Anil Mishra; Sam M Pope; Emily E Muntel; David P Witte; Anthony A Pegg; Paul S Foster; Qutayba Hamid; Marc E Rothenberg Journal: J Clin Invest Date: 2003-06 Impact factor: 14.808
Authors: Robert C Strunk; Stanley J Szefler; Brenda R Phillips; Robert S Zeiger; Vernon M Chinchilli; Gary Larsen; Kevin Hodgdon; Wayne Morgan; Christine A Sorkness; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2003-11 Impact factor: 10.793
Authors: Carol L Rosen; Michael R Debaun; Robert C Strunk; Susan Redline; Sinziana Seicean; Daniel I Craven; Johanna C D Gavlak; Olu Wilkey; Baba Inusa; Irene Roberts; R Lucas Goodpaster; Beth Malow; Mark Rodeghier; Fenella J Kirkham Journal: Pediatrics Date: 2014-07-14 Impact factor: 7.124
Authors: Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall Journal: Transl Res Date: 2015-03-16 Impact factor: 7.012
Authors: Sara C Sadreameli; Rachel O Alade; Peter J Mogayzel; Sharon McGrath-Morrow; John J Strouse Journal: Pediatr Allergy Immunol Pulmonol Date: 2017-12-01 Impact factor: 1.349
Authors: Kirkwood A Pritchard; Thom R Feroah; Sandhya D Nandedkar; Sandra L Holzhauer; William Hutchins; Marie L Schulte; Robert C Strunk; Michael R Debaun; Cheryl A Hillery Journal: Am J Respir Cell Mol Biol Date: 2011-10-27 Impact factor: 6.914
Authors: Robyn T Cohen; Mark Rodeghier; Fenella J Kirkham; Carol L Rosen; Jane Kirkby; Michael R DeBaun; Robert C Strunk Journal: J Allergy Clin Immunol Date: 2016-08-09 Impact factor: 10.793
Authors: Jeffrey A Glassberg; Annie Chow; Juan Wisnivesky; Ronald Hoffman; Michael R Debaun; Lynne D Richardson Journal: Br J Haematol Date: 2012-09-12 Impact factor: 6.998